Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Chinese Patent Office
Express Scripts
Julphar
Healthtrust
US Department of Justice
Mallinckrodt
Federal Trade Commission

Generated: September 25, 2018

DrugPatentWatch Database Preview

Takeda Pharms Na Company Profile

« Back to Dashboard

What is the competitive landscape for TAKEDA PHARMS NA, and what generic alternatives to TAKEDA PHARMS NA drugs are available?

TAKEDA PHARMS NA has three approved drugs.

There is one US patent protecting TAKEDA PHARMS NA drugs.

Summary for Takeda Pharms Na
US Patents:1
Tradenames:5
Ingredients:2
NDAs:3

Drugs and US Patents for Takeda Pharms Na

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-001 May 3, 2001 DISCN No No ➤ Sign Up ➤ Sign Up
Takeda Pharms Na PREVACID NAPRAPAC 375 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-003 Nov 14, 2003 DISCN No No ➤ Sign Up ➤ Sign Up
Takeda Pharms Na PREVACID IV lansoprazole INJECTABLE;INTRAVENOUS 021566-001 May 27, 2004 DISCN Yes No 7,396,841*PED ➤ Sign Up Y ➤ Sign Up
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-002 May 3, 2001 DISCN No No ➤ Sign Up ➤ Sign Up
Takeda Pharms Na PREVACID NAPRAPAC 250 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-002 Nov 14, 2003 DISCN Yes No ➤ Sign Up ➤ Sign Up
Takeda Pharms Na PREVACID NAPRAPAC 500 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-004 Nov 14, 2003 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Takeda Pharms Na

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Na PREVACID IV lansoprazole INJECTABLE;INTRAVENOUS 021566-001 May 27, 2004 4,628,098*PED ➤ Sign Up
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-002 May 3, 2001 4,689,333 ➤ Sign Up
Takeda Pharms Na PREVACID NAPRAPAC 500 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-004 Nov 14, 2003 4,628,098*PED ➤ Sign Up
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-001 May 3, 2001 5,026,560*PED ➤ Sign Up
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-001 May 3, 2001 5,045,321*PED ➤ Sign Up
Takeda Pharms Na PREVACID lansoprazole FOR SUSPENSION, DELAYED RELEASE;ORAL 021281-001 May 3, 2001 5,013,743*PED ➤ Sign Up
Takeda Pharms Na PREVACID NAPRAPAC 500 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-004 Nov 14, 2003 5,433,959*PED ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for TAKEDA PHARMS NA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Orally Disinte 15 mg and 30 mg ➤ Subscribe 2006-12-27
➤ Subscribe Delayed-release Pellets/Capsul 15 mg and 30 mg ➤ Subscribe 2005-12-05

Supplementary Protection Certificates for Takeda Pharms Na Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0021 Belgium ➤ Sign Up PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
C0021 Belgium ➤ Sign Up PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
14/008 Ireland ➤ Sign Up PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Mallinckrodt
Express Scripts
Argus Health
Boehringer Ingelheim
Colorcon
Dow
Accenture
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.